Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$3.26B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
$268M |
| 3 |
Baxter International
BAX
|
$212M |
| 4 |
UnitedHealth
UNH
|
$185M |
| 5 |
Corteva
CTVA
|
$169M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$296M |
| 2 |
Microsoft
MSFT
|
$260M |
| 3 |
Meta Platforms (Facebook)
META
|
$251M |
| 4 |
Salesforce
CRM
|
$226M |
| 5 |
Match Group
MTCH
|
$188M |
Sector Composition
| 1 | Technology | 22.84% |
| 2 | Healthcare | 15.09% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Gilead Sciences
GILD
$140B
| $493M | 0.2% |
7,991,520
+1,123,549
| +16% | +$69.3M |
|
|
102
iShares Russell 1000 Growth ETF
IWF
$117B
| $490M | 0.2% |
2,327,138
+1,275,425
| +121% | +$268M |
|
103
Adobe
ADBE
$148B
| $489M | 0.2% |
1,776,340
-8,238
| -0.5% | -$2.27M |
|
104
Target
TGT
$42B
| $488M | 0.2% |
3,291,551
-115,208
| -3% | -$17.1M |
|
105
Fidelity National Information Services
FIS
$35.6B
| $484M | 0.2% |
6,399,413
+246,537
| +4% | +$18.6M |
|
106
T-Mobile US
TMUS
$284B
| $481M | 0.19% |
3,584,566
-1,072,220
| -23% | -$144M |
|
107
Waste Connections
WCN
$46.5B
| $476M | 0.19% |
3,525,467
-92,281
| -3% | -$12.5M |
|
108
CVS Health
CVS
$93B
| $472M | 0.19% |
4,954,072
-60,930
| -1% | -$5.81M |
|
109
Edwards Lifesciences
EW
$47.7B
| $460M | 0.19% |
5,561,148
-1,048,938
| -16% | -$86.7M |
|
110
Humana
HUM
$37.5B
| $455M | 0.18% |
938,378
-38,868
| -4% | -$18.9M |
|
111
Blackrock
BLK
$170B
| $450M | 0.18% |
818,333
+1,230
| +0.2% | +$677K |
|
112
IBM
IBM
$227B
| $444M | 0.18% |
3,739,993
-614,061
| -14% | -$73M |
|
|
HZNP
113
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $430M | 0.17% |
6,954,570
-41,263
| -0.6% | -$2.55M |
|
114
Intel
INTC
$105B
| $427M | 0.17% |
16,563,996
-2,270,047
| -12% | -$58.5M |
|
115
Crown Holdings
CCK
$10.7B
| $425M | 0.17% |
5,239,145
+43,471
| +0.8% | +$3.52M |
|
116
Equinix
EQIX
$74.6B
| $424M | 0.17% |
745,842
-5,075
| -0.7% | -$2.89M |
|
117
PNC Financial Services
PNC
$80.7B
| $416M | 0.17% |
2,783,926
-3,380
| -0.1% | -$505K |
|
118
Trane Technologies
TT
$90.9B
| $415M | 0.17% |
2,863,785
+119,444
| +4% | +$17.3M |
|
119
Boston Scientific
BSX
$159B
| $409M | 0.17% |
10,552,928
+1,036,331
| +11% | +$40.1M |
|
120
AstraZeneca
AZN
$255B
| $409M | 0.17% |
7,451,678
-74,846
| -1% | -$4.1M |
|
121
MetLife
MET
$53.6B
| $408M | 0.17% |
6,714,845
+582,095
| +9% | +$35.4M |
|
|
122
Baxter International
BAX
$12.1B
| $407M | 0.16% |
7,554,781
+3,941,371
| +109% | +$212M |
|
123
Sherwin-Williams
SHW
$90.5B
| $403M | 0.16% |
1,970,152
-172,498
| -8% | -$35.3M |
|
124
Public Storage
PSA
$51.2B
| $395M | 0.16% |
1,349,319
-48,772
| -3% | -$14.3M |
|
125
Uber
UBER
$194B
| $392M | 0.16% |
14,783,988
+1,122,552
| +8% | +$29.7M |
|